MA
AQST icon

MONECO Advisors’s Aquestive Therapeutics AQST Stock Holding History

MONECO Advisors’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,515
Closed -$249K – 516
2025
Q4 		$249K Buy
38,515
+650
+2% +$4.05K 0.02% 440
2025
Q3 		$212K Buy
37,865
+19,500
+106% +$84.3K 0.02% 471
2025
Q2 		$60.8K Buy
18,365
+1,965
+12% +$5.64K 0.01% 467
2025
Q1 		$47.6K Sell
16,400
-27,500
-63% -$83.2K ﹤0.01% 454
2024
Q4 		$156K Buy
+43,900
New +$202K 0.02% 460

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MONECO Advisors's AQST Position: Q1 2026 in Review

MONECO Advisors sold out of Aquestive Therapeutics (AQST) in Q1 2026, closing a stake of 38,515 shares — an estimated $249K sold.

MONECO Advisors first reported a position in AQST in Q4 2024 and held it in 5 quarters. The position peaked at $249K in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • MONECO Advisors reported no remaining Aquestive Therapeutics position as of Q1 2026 after selling out during the quarter.
  • MONECO Advisors sold 38,515 Aquestive Therapeutics shares in Q1 2026, an estimated $249K.
  • MONECO Advisors first reported a position in Aquestive Therapeutics in Q4 2024 and held it in 5 quarters.
  • MONECO Advisors's Aquestive Therapeutics position peaked at $249K in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on MONECO Advisors's 13F filing for Q1 2026, filed 8 May 2026.